EUVIMEDEUVIMED entdecken
Crossref

Biotinylated Self-Assembled Cytarabine Nano-Prodrug with Enhanced Targetability and Anticancer Efficacy: An In Vitro Study

Xiaoshuang Dai, Daobin Jiang, Chunlin Gou, Ke Mei, Bin Sun, Jianpeng Liu, Na Yao, Xinyu Liu, Neng Qiu iD

Langmuir · 10.06.2025 · 41 (22) · 14197-14210

DOI: 10.1021/acs.langmuir.5c01147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langmuir, online erschienen am 01.06.2025. Verfasst von Xiaoshuang Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Ecology and Environment, Chengdu University of Technology, Chengdu 610059, China. Hauptthemen laut MEDLINE: Cytarabine, Prodrugs, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Key Research and Development Project of Sichuan Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we developed a tumor-target biotinylated cytarabine (Ara-C) prodrug linked through a disulfide bond (Bio-SS-Ara). To enhance its delivery, Bio-SS-Ara was found to be able to self-assemble into uniform nanoparticles (BSSA NPs) with an average particle size of 230 nm, a PDI of 0.265, a critical micelle concentration (CMC) of 5.89 μg/mL, and a zeta potential of -15 mV. BSSA NPs showed good storage stability over 6 weeks. In a glutathione-rich environment, the drug release of BSSA NPs was more rapid than that of BCCA NPs. Concentration-dependent size analysis suggested that BSSA NPs were formed through a dynamic, reversible assembly process. Cellular uptake studies showed significantly increased internalization of BSSA NPs compared to free Ara-C, with enhancements of 4.13-fold in HeLa cells and 3.13-fold in A549 cells. Cytotoxicity assays demonstrated enhanced efficacy, reducing the IC50 by 67.9% in HeLa and 45.2% in A549 cells. The migration rate of HeLa cells was reduced to 14% after BSSA NPs treatment, in comparison with Ara-C treatment, and nuclear shrinkage and fragmentation were observed, indicating the potential of BSSA NPs to limit tumor progression and induce apoptosis. Importantly, no hemolysis was observed in BSSA NPs-treated groups, confirming their good biocompatibility. These findings suggest that BSSA NPs represent a promising strategy for targeted cancer therapy, combining enhanced drug delivery, antitumor efficacy, and biocompatibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytarabineProdrugsNanoparticlesAntineoplastic AgentsHumansParticle SizeBiotinylationHeLa CellsDrug LiberationDrug Screening Assays, AntitumorCell SurvivalA549 Cells

Substanzen

CytarabineProdrugsAntineoplastic Agents

Autor:innen und Institutionen

  • College of Ecology and Environment, Chengdu University of Technology, Chengdu 610059, China.
  • College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology, Chengdu 610059, China.

ORCID-Profile: Neng Qiu

Förderung

  • Key Research and Development Project of Sichuan Provincial Department of Science and Technology

Zitieren

APA

Dai, X., Jiang, D., Gou, C., Mei, K., Sun, B., Liu, J., Yao, N., Liu, X., & Qiu, N. (2025). Biotinylated Self-Assembled Cytarabine Nano-Prodrug with Enhanced Targetability and Anticancer Efficacy: An In Vitro Study. Langmuir, 41(22), 14197-14210. https://doi.org/10.1021/acs.langmuir.5c01147

Vancouver

Dai X, Jiang D, Gou C, Mei K, Sun B, Liu J, et al. Biotinylated Self-Assembled Cytarabine Nano-Prodrug with Enhanced Targetability and Anticancer Efficacy: An In Vitro Study. Langmuir. 2025;41(22):14197-14210. doi:10.1021/acs.langmuir.5c01147

BibTeX
@article{Dai2025,
  author = {Dai, Xiaoshuang and Jiang, Daobin and Gou, Chunlin and Mei, Ke and Sun, Bin and Liu, Jianpeng and Yao, Na and Liu, Xinyu and Qiu, Neng},
  title = {Biotinylated Self-Assembled Cytarabine Nano-Prodrug with Enhanced Targetability and Anticancer Efficacy: An In Vitro Study},
  journal = {Langmuir},
  year = {2025},
  volume = {41},
  number = {22},
  pages = {14197--14210},
  doi = {10.1021/acs.langmuir.5c01147}
}
Kostenlos starten →